Structural Basis of Pharmacological Chaperoning for Human β-Galactosidase
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural Basis of Pharmacological Chaperoning for Human β-Galactosidase
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 21, Pages 14560-14568
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-04-16
DOI
10.1074/jbc.m113.529529
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease
- (2013) Yoshiyuki Suzuki BRAIN & DEVELOPMENT
- A Bicyclic 1-Deoxygalactonojirimycin Derivative as a Novel Pharmacological Chaperone for GM1 Gangliosidosis
- (2013) Tomoko Takai et al. MOLECULAR THERAPY
- Enzyme Replacement Therapy for Lysosomal Diseases: Lessons from 20 Years of Experience and Remaining Challenges
- (2012) R.J. Desnick et al. Annual Review of Genomics and Human Genetics
- Concise syntheses of potent chaperone drug candidates, N-octyl-4-epi-β-valinenamine (NOEV) and its 6-deoxy derivative, from (+)-proto-quercitol
- (2012) Shinichi Kuno et al. CARBOHYDRATE RESEARCH
- Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis
- (2012) M. Aguilar-Moncayo et al. CHEMICAL COMMUNICATIONS
- sp2-Iminosugar O-, S-, and N-Glycosides as Conformational Mimics of α-Linked Disaccharides; Implications for Glycosidase Inhibition
- (2012) Elena M. Sánchez-Fernández et al. CHEMISTRY-A EUROPEAN JOURNAL
- Presenting your structures: theCCP4mgmolecular-graphics software
- (2011) S. McNicholas et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human β-galactosidase
- (2011) Kimihito Usui et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase
- (2011) Abigail I. Guce et al. CHEMISTRY & BIOLOGY
- Pharmacological chaperone therapy for Gaucher disease: a patent review
- (2011) Juan M Benito et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency
- (2011) Katsumi Higaki et al. HUMAN MUTATION
- Crystal Structure of Human β-Galactosidase
- (2011) Umeharu Ohto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: Effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase
- (2011) Matilde Aguilar-Moncayo et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison withN-(n-nonyl)Deoxynojirimycin
- (2009) Zhuo Luan et al. CHEMBIOCHEM
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid β-galactosidase
- (2009) Doris Hofer et al. HUMAN MUTATION
- Substrate reduction therapy
- (2008) Frances M Platt et al. ACTA PAEDIATRICA
- Molecular Basis for β-Glucosidase Inhibition by Ring-Modified Calystegine Analogues
- (2008) Matilde Aguilar et al. CHEMBIOCHEM
- A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
- (2007) Jian-Qiang Fan BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now